Answers are grounded in this paper and cite their sources.
Reverse sequence screening for syphilis using treponemal chemiluminescent immunoassays (Tp-CIAs) is widely used in clinical laboratories; however, interpretation is typically based on binary cutoff values, and the clinical value of signal intensity remains underutilized. We conducted a retrospective diagnostic performance accuracy study including 1,827 individuals undergoing routine screening to evaluate the clinical utility of the Tp-CIA cutoff index (COI) as a continuous variable, using the TPPA as the reference standard. ROC analysis was performed to determine the optimal cutoff, and associations between COI values and TPPA reactivity were assessed. Tp-CIA demonstrated excellent discrimination of TPPA reactivity (area under the curve 0.992). COI values showed a strong monotonic association with TPPA reactivity (Spearman r s = 0.855), increasing from 2.5% at a COI <1 to 99.8% at a COI ≥30. An exploratory cutoff of COI = 3.25 increased specificity from 88.6% to 96.4%, with a corresponding decrease in sensitivity from 99.1% to 95.9%, compared with the manufacturer-recommended cutoff of 1.0. Discordant results (3.9%) were largely confined to low COI values, whereas high COI values were strongly associated with TPPA reactivity. Diagnostic performance remained consistent across HIV subgroups. Among individuals with concurrent non-treponemal testing, COI values were positively correlated with ordered rapid plasma reagin ( r s = 0.637) and toluidine red unheated serum test ( r s = 0.705) titer levels. These findings demonstrate that, within the analytical conditions of this study, higher assay-specific COI values were associated with a greater likelihood of TPPA reactivity. COI-based interpretation should remain supplementary to established confirmatory testing and clinical assessment; exploratory threshold requires independent analytical and clinical validation. IMPORTANCE Syphilis remains a growing global public health concern, and reverse sequence screening using Treponema pallidum chemiluminescent immunoassay (Tp-CIA) is widely adopted. Although these assays are interpreted qualitatively using manufacturer-defined cutoffs, the underlying signal intensity varies across specimens. In this study cohort, increasing Tp-CIA cutoff index (COI) values were associated with an increasing observed proportion of TPPA-reactive results. This association was assay- and cohort-specific and should be interpreted descriptively. COI should not replace established confirmatory testing, quantitative non-treponemal testing, or clinical assessment, and its potential supplementary value requires independent analytical and clinical validation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: